Surrounded by barbed wire and an electric fence, marijuana plants flourish under the bright sun on a farm in a mountainous area outside Rio de Janeiro.
Yet this farm has nothing to do with drug trafficking. It belongs to a pioneering Brazilian nongovernmental organization (NGO) engaged in the production of medical cannabis to help people with seizures.
Margarete Brito, a lawyer by training, first started growing cannabis several years ago to relieve the seizures of her daughter, Sofia, now 12, who has epilepsy.
Photo: AFP
After seeing her condition improve, Brito decided to help other people, too. So she founded the Medical Cannabis Research and Patient Support Association (APEPI), which produces artisanal therapeutic oils made from cannabis to help people with conditions similar to her daughter’s.
That work has required a lot of effort, as growing marijuana remains illegal in Brazil.
“If we follow the letter of the law, nothing authorizes us to do that,” Brito said.
However, she and her husband, Marcos Langenbach, were able to obtain an unprecedented judicial authorization to cultivate cannabis for medical purposes in 2016.
Today, their farm — about two hours by car from the Brazilian capital — has 2,000 plants growing there to help people with severe autism, multiple sclerosis and epilepsy.
Despite initial suspicion and pushback from some, Brito said the endeavor enjoys support in Brazil.
“We have real social legitimacy. That’s what protects us,” Brito said.
On a recent visit to the farm, agricultural engineer Diogo Fonseca made his way among marijuana plants growing in large black pots and marked with the names of their different varieties: Purple Wreck, Schanti, Doctor, Harle Tsu, Solar and CBG.
These plants are used to produce therapeutic oils that meet the needs of each patient, depending on whether they require a higher or lower dose of cannabidiol, a non-psychotropic substance with a relaxing effect.
Using a pocket microscope, Fonseca examines each plant to assess the ideal time to pick.
In April, armed police with sniffer dogs raided the farm, after a person who had worked on renovating its laboratory reported APEPI to the authorities.
“A lot of people have prejudices,” Brito said. “We explain how our project works to everyone, but this person believed that we were drug traffickers and informed against us,” farm manager Manoel Caetano said.
The police eventually realized the farm was a medical cannabis plantation, apologized and left, Brito said.
APEPI has forged partnerships with respected scientific institutions, such as the Oswaldo Cruz Foundation and the University of Campinas. It has grown fivefold over the past two years and now counts 1,500 members.
Among them is Gabriel Guerra, 19, who has a severe form of autism and cerebral palsy. When he was eight, he would have 60 seizures a day.
“But when he started to take the custom oil” — a few drops three times a day — “the attacks stopped,” said his father, Ricardo Guerra.
“He started to have more independence, looking for ways to communicate,” Guerra said.
Thanks to APEPI, the products have become much more accessible: 150 reais (US$28.12) for a 30ml bottle, while imported products can cost anywhere from 600 reais to 3,000 reais.
APEPI is now awaiting a court decision that they hope will allow the farm to increase its production to 10,000 plants from next year.
However, the group is not very optimistic about the prospect of medical cannabis being legalized any time soon — Brazilian President Jair Bolsonaro has already said that he would veto a bill being debated in the Brazilian National Congress.
CHIP RACE: Three years of overbroad export controls drove foreign competitors to pursue their own AI chips, and ‘cost US taxpayers billions of dollars,’ Nvidia said China has figured out the US strategy for allowing it to buy Nvidia Corp’s H200s and is rejecting the artificial intelligence (AI) chip in favor of domestically developed semiconductors, White House AI adviser David Sacks said, citing news reports. US President Donald Trump on Monday said that he would allow shipments of Nvidia’s H200 chips to China, part of an administration effort backed by Sacks to challenge Chinese tech champions such as Huawei Technologies Co (華為) by bringing US competition to their home market. On Friday, Sacks signaled that he was uncertain about whether that approach would work. “They’re rejecting our chips,” Sacks
Taiwan’s exports soared 56 percent year-on-year to an all-time high of US$64.05 billion last month, propelled by surging global demand for artificial intelligence (AI), high-performance computing and cloud service infrastructure, the Ministry of Finance said yesterday. Department of Statistics Director-General Beatrice Tsai (蔡美娜) called the figure an unexpected upside surprise, citing a wave of technology orders from overseas customers alongside the usual year-end shopping season for technology products. Growth is likely to remain strong this month, she said, projecting a 40 percent to 45 percent expansion on an annual basis. The outperformance could prompt the Directorate-General of Budget, Accounting and
NATIONAL SECURITY: Intel’s testing of ACM tools despite US government control ‘highlights egregious gaps in US technology protection policies,’ a former official said Chipmaker Intel Corp has tested chipmaking tools this year from a toolmaker with deep roots in China and two overseas units that were targeted by US sanctions, according to two sources with direct knowledge of the matter. Intel, which fended off calls for its CEO’s resignation from US President Donald Trump in August over his alleged ties to China, got the tools from ACM Research Inc, a Fremont, California-based producer of chipmaking equipment. Two of ACM’s units, based in Shanghai and South Korea, were among a number of firms barred last year from receiving US technology over claims they have
BARRIERS: Gudeng’s chairman said it was unlikely that the US could replicate Taiwan’s science parks in Arizona, given its strict immigration policies and cultural differences Gudeng Precision Industrial Co (家登), which supplies wafer pods to the world’s major semiconductor firms, yesterday said it is in no rush to set up production in the US due to high costs. The company supplies its customers through a warehouse in Arizona jointly operated by TSS Holdings Ltd (德鑫控股), a joint holding of Gudeng and 17 Taiwanese firms in the semiconductor supply chain, including specialty plastic compounds producer Nytex Composites Co (耐特) and automated material handling system supplier Symtek Automation Asia Co (迅得). While the company has long been exploring the feasibility of setting up production in the US to address
RSS